Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Plague - Overview
Plague - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Plague - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Plague - Companies Involved in Therapeutics Development
Achaogen Inc
Aradigm Corp
Greffex Inc
iBio Inc
Prokarium Ltd
Tetraphase Pharmaceuticals Inc
Plague - Drug Profiles
(anthrax + plague) (multivalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
anthrax + plague vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BDM-I - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ciprofloxacin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GreAnPla - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GrePla - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ISAS-02 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
plague (trivalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
plague vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
plague vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
plague vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
plague vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
plague vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
plazomicin sulfate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
pneumonic plaque vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Plague - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
TP-271 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
VypVaxDuo - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Plague - Dormant Projects
Plague - Discontinued Products
Plague - Product Development Milestones
Featured News & Press Releases
Feb 14, 2019: Achaogen submits response to ASPR/BARDA request for information (RFI) for antimicrobial resistance project BioShield
Mar 08, 2017: DynPorts clinical stage recombint Yersinia pestis rF1V plague vaccine to benefit from FDA Orphan Drug Desigtion
Feb 14, 2013: BioDiem Extends Cooperative Agreement With USAMRIID
Jun 05, 2008: Computer Sciences Corporation’s DynPort Vaccine Company To Continue Plague Vaccine Development
Nov 18, 2005: Computer Sciences Corporation’s DynPort Vaccine Company Reaches Milestone In Plague Vaccine Clinical Trial
May 17, 2005: Wake Forest Scientists Find New Combition Vaccine Effective Against Plague
Jan 10, 2005: Computer Sciences Corporation’s DynPort Vaccine Company Enters Clinical Trial For Plague Vaccine Candidate
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Plague, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Number of Products by Targets, H2 2019
Number of Products by Stage and Targets, H2 2019
Number of Products by Mechanism of Actions, H2 2019
Number of Products by Stage and Mechanism of Actions, H2 2019
Number of Products by Routes of Administration, H2 2019
Number of Products by Stage and Routes of Administration, H2 2019
Number of Products by Molecule Types, H2 2019
Number of Products by Stage and Molecule Types, H2 2019


List of Tables


Number of Products under Development for Plague, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Products under Development by Companies, H2 2019
Products under Development by Universities/Institutes, H2 2019
Number of Products by Stage and Target, H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Plague - Pipeline by Achaogen Inc, H2 2019
Plague - Pipeline by Aradigm Corp, H2 2019
Plague - Pipeline by Greffex Inc, H2 2019
Plague - Pipeline by iBio Inc, H2 2019
Plague - Pipeline by Prokarium Ltd, H2 2019
Plague - Pipeline by Tetraphase Pharmaceuticals Inc, H2 2019
Plague - Dormant Projects, H2 2019
Plague - Discontinued Products, H2 2019